Kamada KMDA
NASDAQ KMDA
$8.69 +0.07 (+0.87%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kamada (KMDA) Total Current Liabilities (2012 - 2026)

Updated

Kamada (KMDA) reported Total Current Liabilities of $49.16 million for the quarter ended Jun 30, 2026, up 7.4% from $45.77 million a year earlier but down 17.8% from the prior quarter.

Analysis

Kamada (KMDA) Total Current Liabilities (2012 - 2026) Analysis & Trends

As of Dec 31, 2025, Kamada posted Total Current Liabilities of $47.39 million, down 4.0% from the prior year.

  • Total Current Liabilities has declined for three consecutive years, though with a five-year compound annual growth rate of 13.7% (years ended Dec 2020 to Dec 2025).
  • By year, Total Current Liabilities came in at $49.39 million in the year ended Dec 31, 2024 (-0.4%), $49.59 million in the year ended Dec 31, 2023 (-34.5%), $75.71 million in the year ended Dec 31, 2022 (+40.0%) and $54.06 million in the year ended Dec 31, 2021 (+116.5%).
  • Five-year quarterly Total Current Liabilities spans a low of $26.59 million in the quarter ended Sep 30, 2021 and a high of $75.71 million in the quarter ended Dec 31, 2022.
  • Year over year, Total Current Liabilities gained in five of the last eight quarters, with growth averaging 13.1%.
  • The high point for year-over-year Total Current Liabilities in five years was the quarter ended Sep 30, 2022 (growth of 160.1%); the low point was the quarter ended Mar 31, 2024 (a decline of 46.3%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $59.78 million (quarter ended Mar 31, 2026), $47.39 million (quarter ended Dec 31, 2025) and $47.84 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Kamada 497.25 Mn 206.31 Mn 22.47 Mn 49.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 49.16 Mn
Mar 31, 2026 59.78 Mn
Dec 31, 2025 47.39 Mn
Sep 30, 2025 47.84 Mn
Jun 30, 2025 45.77 Mn
Mar 31, 2025 57.05 Mn
Dec 31, 2024 49.39 Mn
Sep 30, 2024 34.00 Mn
Jun 30, 2024 40.90 Mn
Mar 31, 2024 37.18 Mn
Dec 31, 2023 49.59 Mn
Sep 30, 2023 37.27 Mn
Jun 30, 2023 65.83 Mn
Mar 31, 2023 69.28 Mn
Dec 31, 2022 75.71 Mn
Sep 30, 2022 69.15 Mn
Jun 30, 2022 49.68 Mn
Mar 31, 2022 42.23 Mn
Dec 31, 2021 54.06 Mn
Sep 30, 2021 26.59 Mn
API Access

Kamada Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=KMDA&period=max&api_key=YOUR_API_KEY